Feature|Events|September 3, 2026

BioPharm International

  • BioPharm International September October 2026
  • Volume 39
  • Issue 5

Holding the Line: Why Differential Pressure Is Critical in GMP Cleanrooms

Author(s)Eric Bankos
Fact checked by: Ron Panarotti

GMP cleanroom differential pressure control prevents FDA 483 citations and contamination failures through HVAC design and validation.

In today’s high‑stakes world of pharmaceutical and biotech manufacturing, environmental control isn’t just a checkbox; it’s a battlefield. Differential pressure may operate quietly in the background, but when it’s ignored, the consequences can be catastrophic, involving contaminated batches, FDA warning letters, costly recalls, and even shutdowns. On the flip side, mastering differential pressure means having airtight quality, audit‑ready compliance, and safeguarding product and reputation.

Related to this article

The Promise of Microgravity for R&D and Manufacturing
As access to low Earth orbit expands, space-based research is opening possibilities in drug discovery, formulation, and manufacturing. In Part 1, the authors look at how microgravity changes biology and chemistry in ways that can’t be reproduced on Earth and where it fits from target discovery to life cycle management.